The largest database of trusted experimental protocols
> Chemicals & Drugs > Organic Chemical > 5-fluoroorotic acid

5-fluoroorotic acid

5-Fluoroorotic acid is a synthetic analog of the naturally occurring pyrimidine orotate.
It has been used as a selective inhibitor of de novo pyrimidine biosynthesis and as a tool in studies of nucleic acid metabolism. 5-Fluoroorotic acid may also have potential applications in cancer research and treatment.
Researchers can optimize their 5-fluoroorotic acid experiments using PubCompare.ai, an AI-driven platform for research reproducibility.
PubCompare.ai helps locate protocols from literature, preprints, and patents, and provides AI-driven comparisons to identify the best protocols and products.
This streamlines the research process and maximizes experimental results.

Most cited protocols related to «5-fluoroorotic acid»


Escherichia coli TOP10 (Invitrogen) and E. coli CA434 [39] (link) were cultured in Luria-Bertani (LB) medium, supplemented with chloramphenicol (25 µg/ml), where appropriate. Routine cultures of C. difficile 630 Δerm[40] (link) and C. difficile R20291 were carried out in BHIS medium (brain heart infusion medium supplemented with 5 mg/ml yeast extract and 0.1% [wt/vol] L-cysteine) [41] (link). C. difficile medium was supplemented with D-cycloserine (250 µg/ml), cefoxitin (8 µg/ml), lincomycin (20 µg/ml), and/or thiamphenicol (15 µg/ml) where appropriate. A defined minimal media [18] (link) was used as uracil-free medium when performing genetic selections. A basic nutritive mannitol broth for growth assays of C. difficile strains were prepared as follows : Proteose peptone no. 2 4% [wt/vol] (BD Diagnostics, USA), sodium phosphate dibasic 0.5%[wt/vol], potassium phosphate monobasic 0.1%[wt/vol], sodium chloride, 0.2% [wt/vol], magnesium sulfate, 0.01% [wt/vol], mannitol, 0.6% [wt/vol] with final pH at +/−7.35. For solid medium, agar was added to a final concentration of 1.0% (wt/vol). Clostridium sporogenes ATCC 15579 was cultivated in TYG media [7] (link). All Clostridium cultures were incubated in an anaerobic workstation at 37°C (Don Whitley, Yorkshire, United Kingdom). Uracil was added at 5 µg/ml, and 5-Fluoroorotic acid (5-FOA) at 2 mg/ml. All reagents, unless noted, were purchased from Sigma-Aldrich.
Full text: Click here
Publication 2013
5-fluoroorotic acid Agar Biological Assay Brain Cefoxitin Chloramphenicol Clostridium Clostridium sporogenes Cycloserine Cysteine Diagnosis Escherichia coli Genetic Selection Heart Lincomycin Mannitol potassium phosphate proteose-peptone Sodium Chloride sodium phosphate Strains Sulfate, Magnesium Thiamphenicol Uracil Yeast, Dried

Escherichia coli strain DH5α was used to propagate all plasmids. The Aspergillus species used for implementation of CRISPR-Cas9 are listed in Table 2. Genomic DNA (gDNA) from fungal strains was isolated via FastDNA SPIN Kit for Soil DNA extraction kit (MP Biomedicals, USA). The mutant strains made in this study are listed in Table 1. All aspergilli were cultivated on standard solid glucose based minimal medium (MM) (1% glucose, 1x nitrate salt solution [41 ], 0.001% Thiamine, 1x trace metal solution [42 (link)], 2% agar), supplemented with 10 mM uridine (Uri), 10 mM uracil (Ura), and/or 4 mM L-arginine (Arg) when required. Solid plates containing 5-fluoroorotic acid (5-FOA) were made as MM+Arg+Uri+Ura supplemented with filter-sterilized 5-FOA (Sigma-Aldrich) to a final concentration of 1.3 mg/ml. For transformation media (TM) glucose was replaced with 1 M sucrose.
Full text: Click here
Publication 2015
5-fluoroorotic acid Agar Arginine Aspergillus Clustered Regularly Interspaced Short Palindromic Repeats DNA, Fungal Escherichia coli Genome Glucose Metals Nitrates Plasmids Strains Sucrose Thiamine Uracil Uridine
Transformations were performed with a standard lithium acetate method. To construct Z3EV and Z4EV strains, the Gal4dbd of GEV was deleted by PCR-mediated disruption with URA3. Zif268 and Z4 DNA-binding domains with homology to the ER and ACT1 promoter were then transformed into cells and selected via 5-Fluoroorotic Acid (5-FOA) counter selection of URA3. Single colonies were isolated and sequenced to verify the presence of the proper DNA-binding domain (Supplementary Figure S1A).
The reporter plasmid was created from the base plasmid pRS416 (gift from Megan McClean), a CEN plasmid containing the URA3 selectable marker. The GAL1 promoter region was amplified from genomic DNA. Overlap-extension PCR was used to add the restriction enzyme sites for XbaI and NotI, respectively, on either side of the region of the three continuous Gal4p-binding sites 5′-CGG-N11-CCG-3′ (22 ). This promoter fragment was then cloned into pRS416 in front of green fluorescent protein (GFP) using the restriction enzymes NheI and XmaI. Before zinc-finger-binding sites were added the XbaI site in GFP was re-coded using a silent mutation to remove this restriction site. Finally, the three canonical Gal4p-binding sites were removed via digestion with XbaI and NotI and triplets of dimeric Z3EV and Z4EV-binding sites were cloned into respective plasmids (Supplementary Data and Supplementary Figure S1B).
To construct the inducible GCN4 allele, KanMX-Z4EVpr was amplified from pMN10 with the primers 5′-caatttgtctgctcaagaaaataaattaaatacaaataaaCGCACTTAACTTCGCATCTG-3′ and 5′-tggatttaaagcaaataaacttggctgatattcggacatTATAGTTTTTTCTCCTTGACG-3′ and transformed into Z4EV-containing parent strain. The uppercase portions of the sequences share homology with the KanMX-Z4EVpr cassette on the plasmid pMN10.
Publication 2012
5-fluoroorotic acid Alleles Binding Sites Cells Digestion DNA Restriction Enzymes Genome Green Fluorescent Proteins lithium acetate Oligonucleotide Primers Parent Plasmids Silent Mutation Strains Triplets Zinc Fingers

A. niger strains used in this study are listed in Table 1. Strains were cultivated in minimal medium (MM; (Bennett and Lasure 1991 )) containing 55 mM glucose, 7 mM KCl, 11 mM KH2PO4, 70 mM NaNO3, 2 mM MgSO4, 76 nM ZnSO4, 178 nM H3BO3, 25 nM MnCl2, 18 nM FeSO4, 7.1 nM CoCl2, 6.4 nM CuSO4, 6.2 nM Na2MoO4, 174 nM EDTA; or in complete medium containing, in addition to MM, 0.1% (w/v) casamino acids and 0.5% (w/v) yeast extract. When required, 10 mM uridine and/or 100 µg/ml of hygromycin was added. When using the amdS as selection marker, strains were grown in MM without NaNO3 and supplemented with 10 mM acetamide and 15 mM cesium chloride.

Aspergillus niger strains used in this study

NameGenotypeReference
N402cspA1, amdSBos et al. (1988 (link))
AB4.1pyrG, amdSvan Hartingsveldt et al. (1987 (link))
MA70.15aΔkusA, pyrG, amdS+Meyer et al. (2007 (link))
MA78.6aΔkusA, amdS+This study
NC4.1aΔkusA, pyrG, amdSThis study
NC5.1aΔkusA, pyrG+, amdSThis study
NC6.2ΔkusA, pyrG+, amdS+, ΔhacAThis study
NC7.1ΔkusA, pyrG+, amdS+, ΔireA/ireAThis study
NC8.1ΔkusA, pyrG+, amdS+, ΔhacA, pAMA-hacAThis study
NC9.1ΔkusA, pyrG+, amdS+, ΔireA, pAMA-ireAThis study
MA169.4akusA::DR-amdS-DR, pyrGThis study
MA171.1kusA::DR-amdS-DR, pyrG+, ΔracAThis study
MA172.1kusA+, pyrG+, ΔracAThis study
MK15.AΔkus, pyrG+, ΔsrgAThis study
MK18.AkusA::DR-amdS-DR, pyrG+, ΔsrgAThis study

aStrains have been deposited at the Fungal Genetics Stock Center (www.fgsc.net)

To obtain pyrG strains, 2 × 107 spores were inoculated on MM agar plates supplemented with 0.75 mg/ml 5′-fluoroorotic acid (FOA), 10 mM uridine and 10 mM proline as nitrogen source. Plates were incubated for 1–2 weeks at 30°C. FOA-resistant mutants were isolated, purified and tested for uridine auxotrophy on MM with and without uridine (mutants should not grow on medium lacking uridine). To obtain amdS strains, 2 × 107 spores were inoculated on MM agar plates supplemented with 0.2% 5′-fluoroacetamide (FAA) and 10 mM urea as nitrogen source. After 1–2 weeks incubation at 30°C, FAA-resistant mutants were isolated, purified and tested for growth on acetamide medium (mutants should not grow on medium containing acetamide as sole nitrogen source).
All basic molecular techniques were performed according to standard procedures (Sambrook and Russel 2001 ). Transformation of A. niger, genomic DNA extraction, screening procedures, diagnostic PCR and Southern analysis were conducted as recently described in detail (Meyer et al. 2010 ).
Publication 2010
5-fluoroorotic acid acetamide Agar casamino acids cesium chloride Diagnosis Edetic Acid fluoroacetamide Genes, Fungal Genome Glucose hygromycin A manganese chloride Methyldopa Nitrogen Nitrogen-10 Proline sodium molybdate(VI) Spores Strains Sulfate, Magnesium Urea Uridine Yeast, Dried
The strains used in this study are listed in Table S5. YPD (20 g/L glucose, 20 g/L peptone. 10 g/L yeast extract) was used for routine growth. Lee's + glucose and Lee's + GlcNAc media were used for mating and white-opaque switching assays [17] (link).
The plasmid pSFS2A-URA3 was generated by inserting two DNA fragments containing sequences homologous to the 5′- and 3-terminals of C. albicans URA3 gene into the ApaI/XhoI and SacII/SacI sites of pSFS2A [31] (link). The auxotrophic strain SZ306u for uridine was constructed by disruption of one copy of URA3 with the linearized plasmid pSFS2A-URA3 and then grown on 5-fluoroorotic acid (5-FOA) containing medium. The white-opaque switching-competence of SZ306u was then confirmed. SZ306 and RVVC10 were converted to SZ306a and RVVC10α by deletion of one MTL allele with the plasmid T2A-MTL (Srikantha and Soll, unpublished). The first copy of WOR1 was deleted with the PCR product of pGEM-URA3 with the primers of WOR1-5DR and WOR1-3DR in SZ306u [32] (link). The second copy of WOR1 was then deleted with the linearized plasmid T2A-WOR1 [33] (link). A couple of primer sets were used to confirm the correct disruption of WOR1 in SZ306u.
To construct the WOR1/WOR1::WOR1p-GFP, EFG1/EFG1::EFG1p-GFP, and WH11/WH11::WH11p-GFP strains, CY110 was transformed with PCR products of the GFP-caSAT1 fragment (amplified from the template plasmid pNIM1 with GFP reporter primers, Table S6) [34] (link). The forward primers contained 60 bp of hanging homology to the promoter region of WOR1, WH11, or EFG1, while the reverse primers contained 60 bp of hanging homology to the 3′-UTR of WOR1, WH11, or EFG1. Correct integration of the transformations was verified by genomic DNA PCR with checking primers. All primers used in this study are listed in Table S6.
Full text: Click here
Publication 2013
5-fluoroorotic acid Alleles Biological Assay Deletion Mutation Genes Genome Glucose methyl 4-azidophenylacetimidate Oligonucleotide Primers Peptones Plasmids prostaglandin M Saccharomyces cerevisiae Strains Uridine

Most recents protocols related to «5-fluoroorotic acid»

Strains and plasmids used in this study are listed in Table 1, whereas primers are listed in Table 2. The genes encoding cdtA and cdtB were deleted from C difficile R20291ΔpyrE using allelic-exchange technology [16 (link)]. To achieve this, left and right homology arms corresponding to the regions annealing immediately upstream and downstream of cdtA/B were amplified by polymerase chain reaction (PCR) using cdtAB LAF/RAR and cdtAB RAF/RAR primer sets, respectively. The homology arms were then spliced together by overlap-extension (SOEing) PCR by means of their overlapping 20-base pair (bp) homologous regions before cloning the ensuing product into pMTL-YN4 using flanking SbfI-AscI restriction sites, thus generating the knockout cassette (KOC) pMTL-YN4-cdtAB KOC. The plasmid was then conjugated into C difficile R20291ΔpyrE exactly as previously described, and transconjugants were selected on the basis of thiamphenicol resistance [17 (link)]. Thereafter, single crossover integrants (SCOs) were identified by 2 parallel PCR screens using cdtAB diag F/YN4 primers for left arm recombinants and YN4 F/cdtAB diag R primers for right arm recombinants, respectively (data not shown). To select for double crossover recombinants, SCO integrants were harvested, diluted 1 × 10−3, and cultured onto C difficile minimal medium (CDMM) [18 (link)] containing 500 µg/mL 5-fluoroorotic acid and 1 µg/mL uracil, to force plasmid loss through the counter-selection marker pyrE and to select for double crossover mutants before confirming plasmid loss on the basis of thiamphenicol sensitivity. The intended deletions were confirmed by PCR analysis using cdtAB diag F/R primers. The deletion mutant generated an approximately 4-kbp product, while its wild-type (WT) counterpart generated a 4.6-kbp product (Figure 1A). Finally, the pyrE allele was restored to WT using pMTL-YN2 exactly as described previously [17 (link)].
Strains differentially producing CDTa or CDTb were generated by the integration of either cdtA or cdtB at the pyrE locus, under the control of cdtA promoter PcdtA. First, cdtA coupled with its native promoter was amplified by PCR using PcdtA F and cdtA R primers, the product of which was cloned into pMTL-YN2C by means of flanking NotI-BamHI restriction sites, thus generating the complementation cassette pMTL-YN2C-PcdtA-cdtA. In a similar fashion, pMTL-YN2C-PcdtA-cdtB was generated by amplifying PcdtA using PcdtA F/PcdtA LAR primers, and cdtB was generated using cdtB RAF/cdtB RAR primers, before SOEing the products together and cloning them into pMTL-YN2C by means of flanking NotI-SalI restriction sites. The CDTb-encoding construct could only be generated with a single-nucleotide polymorphism in the promoter region of PcdtA using an A-G substitution at position-124 relative to the start codon. The resultant plasmids were applied in parallel, to individually integrate the respective CDT constructs at the pyrE locus of R20291ΔpyrEΔcdtAB concomitant with the repair of pyrE, after successful conjugation and selection for uracil prototrophs on CDMM lacking uracil. The PCR analysis using primer pyrE WT F, coupled with either cdtA R or cdtB RAR, demonstrated effective knock-in at the pyrE locus (Figure 1B), thus generating strains R20291ΔcdtAB*PcdtA-cdtA and R20291ΔcdtAB*PcdtA-cdtB.
Publication 2023
5-fluoroorotic acid Alleles Base Pairing CDTA Codon, Initiator Culture Media Deletion Mutation Gene Deletion Genes Hypersensitivity Oligonucleotide Primers Plasmids Polymerase Chain Reaction Single Nucleotide Polymorphism sodium-binding benzofuran isophthalate Strains Thiamphenicol Thiel-Behnke corneal dystrophy Uracil
Thermoccocus kodakarensis was isolated from Kodakara Island, Kagoshima, Japan (Morikawa et al., 1994 (link); Atomi et al., 2004 (link)). T. kodakarensis KU216 (Sato et al., 2003 (link), 2005 (link)) and derivative strains were cultivated under strictly anaerobic conditions at 85°C in nutrient-rich medium (ASW-YT-m1-S0 or ASW-YT-m1-pyruvate) or synthetic medium (ASW-AA-m1-S0). ASW-YT-m1-S0, ASW-YT-m1-pyruvate, and ASW-AA-m1-S0 are modified versions of ASW-YT-S0, ASW-YT-pyruvate, and ASW-AA-S0 media, respectively. ASW-YT-S0 was composed of 0.8 × artificial seawater (ASW) (Robb and Place, 1995 ), 5 g L−1 yeast extract, 5 g L−1 tryptone, and 2 g L−1 elemental sulfur. In ASW-YT-m1-S0, 20 μM KI, 20 μM H3BO3, 10 μM NiCl2, and 10 μM Na2WO4 were supplemented. In ASW-YT-m1-pyruvate medium, elemental sulfur was replaced with 5 g L−1 sodium pyruvate. ASW-AA-S0 was composed of 0.8 × ASW, a mixture of 20 amino acids, modified Wolfe’s trace minerals and a mixture of vitamins (Sato et al., 2003 (link)). In ASW-AA-m1-S0, 20 μM KI, 20 μM H3BO3, 10 μM NiCl2, and 10 μM Na2WO4 were supplemented, and the concentrations of l-arginine hydrochloride and l-valine were increased (from 125 mg L−1 to 250 mg L−1 and from 50 mg L−1 to 200 mg L−1, respectively). When cells without a pyrF gene were grown, 10 μg mL−1 uracil was added to make ASW-AA-m1-S0(+Ura). To remove oxygen in the medium, 5% (w/v) Na2S solution was added until the medium became colorless. Resazurine (0.5 mg L−1) was also added to all media as an oxygen indicator. For solid medium used to isolate transformants, 10 g L−1 gelrite, 7.5 g L−1 5-fluoroorotic acid (5-FOA), 10 μg mL−1 uracil, 4.5 mL of 1 M NaOH and 0.2% (v/v) polysulfide solution (10 g Na2S 9H2O and 3 g sulfur flowers in 15 mL H2O) rather than elemental sulfur was supplemented to ASW-AA-m1 medium. Escherichia coli DH5α (Takara Bio, Kusatsu, Japan) and BL21-Codonplus(DE3)-RIL strains (Agilent Technologies, Santa Clara, CA) were cultivated at 37°C in Lysogeny broth (LB) medium supplemented with ampicillin (100 mg L−1). E. coli DH5α was used for recombinant plasmid construction and E. coli BL21-Codonplus (DE3)-RIL was used for heterologous gene expression. Chemicals were purchased from Wako Pure Chemicals (Osaka, Japan) or Nacalai Tesque (Kyoto, Japan) unless mentioned otherwise.
Full text: Click here
Publication 2023
5-fluoroorotic acid Amino Acids Ampicillin Arginine Hydrochloride Cells Escherichia coli Flowers Gelrite Gene Expression Genes Lysogeny Nutrients Oxygen Plasmids polysulfide Pyruvate Sodium sodium sulfide Strains Sulfur Trace Minerals Uracil Valine Vitamin A Yeast, Dried

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
5-fluoroorotic acid Adenine Amino Acids, Basic Ampicillin citramalate DNA-Directed DNA Polymerase DNA Restriction Enzymes Escherichia coli Genome Glucose Immune Tolerance Nitrogen Nitrogen-16 Oligonucleotides Peptones Pichia kudriavzevii Plasmids Promega Saccharomyces cerevisiae Strains Sulfate, Ammonium tyrosinase-related protein-1 Uracil
Yeast cells were routinely grown at 30 °C in YPD (1% yeast extract, 2% peptone, 2% glucose) medium or in SD (0.15% yeast nitrogen base, 0.5% ammonium sulphate, 2% glucose) broth supplemented with the appropriate amino acids and bases as nutritional requirements [73 ]. All solid media contained 2% agar. Yeast was transformed using the lithium acetate method [74 (link)]. Bacteria were routinely grown in LB (0.5% yeast extract, 1% tryptone, 0.5% NaCl) broth with or without agar, in the presence of 100 µg/mL ampicillin, when required.
To test the in vivo function of the different truncated dbp7 alleles, a dbp7∆ strain harbouring plasmid YCplac33-DBP7 (CEN URA3 DBP7) was transformed with YCplac22 (CEN TRP1) plasmids carrying various dbp7 truncated alleles (see Table S2). Trp+ transformants were selected and streaked out on plates containing 5-fluoroorotic acid (5-FOA) to counter-select for the URA3 plasmid [75 (link)]. Clones growing on these plates were recovered on fresh SD-Trp plates, and their growth was then assessed on YPD and selective SD-Trp media.
Full text: Click here
Publication 2023
5-fluoroorotic acid Agar Alleles Amino Acids Ampicillin Bacteria Cells Clone Cells Glucose lithium acetate Nitrogen Nutritional Requirements Peptones Plasmids Sodium Chloride Strains Sulfate, Ammonium tyrosinase-related protein-1 Yeast, Dried
Standard media and techniques for growing and transforming yeast were used. Strain CGY2 was derived from crossing BY4741 gcs1∆::kanMX with BY4742 glo3∆::kanMX pRS416-GLO3 to generate the double mutant covered by the WT GLO3 plasmid. Strains expressing glo3 mutants were constructed by shuffling in pRS315-glo3 plasmids into CGY2 using 5′-fluoro-orotic acid (5-FOA) plates to eliminate pRS416-GLO3. Yeast strains used in this study are listed in Table S4. Plasmid constructions were performed using standard molecular manipulation. Wild-type GLO3 gene was cloned into pRS315 yeast vectors with an endogenous promoter and terminator sequences. Mutations were introduced using the two-stage quick-change mutagenesis protocol.
Publication 2023
5-fluoroorotic acid Cloning Vectors Faciothoracoskeletal Syndrome Genes Mutagenesis Mutation Plasmids Saccharomyces cerevisiae Strains Terminator Regions, Genetic

Top products related to «5-fluoroorotic acid»

Sourced in United States
5-Fluoroorotic Acid (5-FOA) is a chemical compound used in various laboratory applications. It is a pyrimidine analog that inhibits the growth of cells containing a functional orotidine-5'-phosphate decarboxylase (URA3) gene. This property makes 5-FOA a useful tool in genetic and molecular biology research.
Sourced in United States
5-fluoro-orotic acid (5-FOA) is a chemical compound used in various laboratory applications. It functions as a selective agent for the identification and isolation of yeast or bacterial cells that have lost the ability to utilize uracil. The core function of 5-FOA is to provide a means for researchers to select for specific genetic traits or mutations in their experimental systems.
5-fluoroorotic acid is a chemical compound used in biological research and laboratory applications. It serves as a precursor or intermediate in various biochemical and molecular biology experiments. The core function of 5-fluoroorotic acid is to facilitate specific research processes, but a detailed description of its intended use is not provided to maintain an unbiased and factual approach.
Sourced in United States
5-Fluoroorotic Acid (5-FOA) is a chemical compound used in microbiology and molecular biology research. It is a uracil analog that inhibits the growth of cells that are able to convert it to 5-fluorouracil. This property makes it useful for the selection of yeast and bacterial cells that have lost the ability to metabolize uracil.
5-fluoroorotic acid (5-FOA) is a laboratory reagent used in molecular biology. It is a pyrimidine analog that interferes with the biosynthesis of uracil, an essential component of RNA. 5-FOA is commonly used as a selective agent in genetic screens and assays, allowing for the identification of specific genetic mutations or the isolation of particular cell types.
5-FOA is a chemical compound used in laboratory settings. It is a substrate for 5-fluoroorotic acid decarboxylase, an enzyme involved in pyrimidine biosynthesis. 5-FOA can be used as a selection agent in yeast genetic studies.
5-Fluoroorotic Acid (FOA) is a chemical compound used in molecular biology and genetics research. It is a pyrimidine analog that can be used as a selection agent in yeast and bacterial genetic systems.
5-fluoroorotic acid (5-FOA) is a chemical compound used in molecular biology and genetics research. It serves as a selective agent, allowing for the identification and isolation of specific genetic mutations or cell lines. 5-FOA inhibits the growth of cells that can utilize the uracil biosynthesis pathway, making it a useful tool for researchers studying this cellular process.
Sourced in United States, United Kingdom, Germany, China, France, Australia
Geneticin (G418) is a broad-spectrum antibiotic used as a selectable marker in eukaryotic cell culture. It inhibits protein synthesis, allowing for the selection of cells that have been successfully transfected with a resistance gene.
Sourced in United States
5-FOA is a laboratory reagent used in molecular biology and genetics research. It is a chemical compound that inhibits the growth of cells that express the URA3 gene, which is commonly used as a selectable marker in yeast and other organisms. The core function of 5-FOA is to facilitate the selection and screening of genetic manipulations in various experimental systems.

More about "5-fluoroorotic acid"

5-Fluoroorotic acid (5-FOA) is a synthetic analog of the naturally occurring pyrimidine orotate, which has been widely used in scientific research and has potential applications in cancer treatment.
As a selective inhibitor of de novo pyrimidine biosynthesis, 5-FOA has been instrumental in studies of nucleic acid metabolism, providing valuable insights into cellular processes.
Researchers can optimize their 5-FOA experiments by utilizing the innovative AI-driven platform, PubCompare.ai.
This powerful tool helps researchers locate protocols from literature, preprints, and patents, and provides AI-driven comparisons to identify the best protocols and products for their experiments.
This streamlines the research process and maximizes experimental results, ultimately accelerating scientific discoveries.
In addition to 5-FOA, researchers may also encounter related terms and abbreviations, such as 5-fluoro-orotic acid (5-FOA;) and 5-Fluoroorotic Acid (FOA).
Furthermore, 5-FOA is sometimes used in conjunction with Geneticin (G418), a selective antibiotic used for cell culture applications.
By leveraging the insights and capabilities of PubCompare.ai, researchers can enhance their 5-FOA studies and drive their research forward with greater efficiency and precision.
This AI-powered platform is a valuable resource for maximizing the impact of 5-FOA experiments and advancing scientific knowledge in cancer research and beyond.
OtherTerms: 5-Fluoroorotic acid, 5-fluoro-orotic acid, 5-FOA, 5-Fluoroorotic Acid (FOA), Geneticin (G418)